Atlas Trials

The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes

Clinical trial NCT05719376 · UNKNOWN

Trial details

NCT number
NCT05719376
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Failure, Chronic
Start date
2023-02-01
Primary completion
2026-05-01
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.